Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (18)
Shivam H. Patel, Aditya Belamkar, Amir R. Hajrasouliha, Denis Jusufbegovic & Thomas A. Ciulla. (2022) Progress in the pharmacotherapy of uveitis: the art of personalized care. Expert Opinion on Pharmacotherapy 23:12, pages 1445-1455.
Read now
Read now
Anahita Kate & Sayan Basu. (2022) Systemic Immunosuppression in Cornea and Ocular Surface Disorders: A Ready Reckoner for Ophthalmologists. Seminars in Ophthalmology 37:3, pages 330-344.
Read now
Read now
Luca De Simone, Alessandro Invernizzi, Raffaella Aldigeri, Valentina Mastrofilippo, Chiara Marvisi, Fabrizio Gozzi, Elena Bolletta, Chantal Adani, Nicolò Pipitone, Francesco Muratore, Luigi Fontana, Carlo Salvarani & Luca Cimino. (2022) Effectiveness of Infliximab and Interferon Alpha-2a for the Treatment of Behçet’s Uveitis: Customizing Therapy according to the Clinical Features. Ocular Immunology and Inflammation 30:2, pages 506-514.
Read now
Read now
Keiko Kunimi, Yoshihiko Usui, Masakai Asakage, Chihiro Maehara, Kinya Tsubota, Ryosuke Mitsuhashi, Akihiko Umazume, Takeshi Kezuka, Jun-Ichi Sakai & Hiroshi Goto. (2022) Anti-TNF-α Therapy for Refractory Uveitis Associated with Behçet’s Syndrome and Sarcoidosis: A Single Center Study of 131 Patients. Ocular Immunology and Inflammation 30:1, pages 223-230.
Read now
Read now
Nisha R. Acharya, Sarju Patel, Gelareh Homayounfar, Wayne T. A. Enanoria, Akbar Shakoor, Anindita Chakrabarti & Debra A. Goldstein. (2019) Relapse of Juvenile Idiopathic Arthritis-Associated Uveitis after Discontinuation of Immunomodulatory Therapy. Ocular Immunology and Inflammation 27:4, pages 686-692.
Read now
Read now
Shuai Ming, Kunpeng Xie, Huijuan He, Ya Li & Bo Lei. (2018) Efficacy and safety of adalimumab in the treatment of non-infectious uveitis: a meta-analysis and systematic review. Drug Design, Development and Therapy 12, pages 2005-2016.
Read now
Read now
Wajiha J. Kheir, Carl-Joe Mehanna, Maamoun Abdul Fattah, Sara Al Ghadban, Marwan El Sabban, Ahmad M. Mansour & Rola N. Hamam. (2018) Intravitreal Adalimumab for the Control of Breakthrough Intraocular Inflammation. Ocular Immunology and Inflammation 26:8, pages 1206-1211.
Read now
Read now
Friederike Mackensen, Carsten Heinz, Eva Jakob, Viviane Grewing, Hanns-Martin Lorenz, Arnd Heiligenhaus, Regina Max & Matthias D. Becker. (2018) Randomized Controlled Study to Evaluate the Efficacy of Adalimumab in Patients with Different Forms of Refractory Uveitis. Ocular Immunology and Inflammation 26:7, pages 1015-1022.
Read now
Read now
Audrey-Elodie Mercier, Emmanuel Ribeiro, Jean-François Korobelnik, Marie-Noëlle Delyfer & Marie-Bénédicte Rougier. (2018) Efficacy of Anti-TNF-α Therapy for the Treatment of Non-infectious Uveitis: A Retrospective Study of 21 Patients. Ocular Immunology and Inflammation 26:3, pages 477-484.
Read now
Read now
Khayyam Durrani, John H. Kempen, Gui-shuang Ying, R. Oktay Kacmaz, Pichaporn Artornsombudh, James T. Rosenbaum, Eric B. Suhler, Jennifer E. Thorne, Douglas A. Jabs, Grace A. Levy-Clarke, Robert B. Nussenblatt, C. Stephen Foster$suffix/text()$suffix/text() & Systemic Immunosuppressive Therapy for Eye Diseases (SITE) Research Group. (2017) Adalimumab for Ocular Inflammation. Ocular Immunology and Inflammation 25:3, pages 405-412.
Read now
Read now
Ashwinee Ragam, Anton M. Kolomeyer, Christina Fang, Yinfei Xu & David S. Chu. (2014) Treatment of Chronic, Noninfectious, Nonnecrotizing Scleritis with Tumor Necrosis Factor Alpha Inhibitors. Ocular Immunology and Inflammation 22:6, pages 469-477.
Read now
Read now
Uwe Pleyer & Nicole Stübiger. (2014) New pharmacotherapy options for noninfectious posterior uveitis. Expert Opinion on Biological Therapy 14:12, pages 1783-1799.
Read now
Read now
Anna Cardiakidis Myers, Fredrik Ghosh, Sten Andréasson & Vesna Ponjavic. (2014) Retinal Function and Morphology in the Rabbit Eye after Intravitreal Injection of the TNF Alpha Inhibitor Adalimumab. Current Eye Research 39:11, pages 1106-1116.
Read now
Read now
Denis Wakefield. (2014) Does Cyclophosphamide Still Have a Role in the Treatment of Severe Inflammatory Eye Disease?. Ocular Immunology and Inflammation 22:4, pages 306-310.
Read now
Read now
Sumita Phatak, Rupesh Agrawal & Carlos Pavesio. (2014) Adalimumab: viable treatment option for pediatric refractory uveitis?. Expert Review of Ophthalmology 9:3, pages 175-184.
Read now
Read now
Emmett T. Cunningham$suffix/text()$suffix/text() & Manfred Zierhut. (2014) The Promise and Limitations of TNF-α Inhibition for Uveitis. Ocular Immunology and Inflammation 22:2, pages 87-89.
Read now
Read now
Robert M Beardsley, Eric B Suhler, James T Rosenbaum & Phoebe Lin. (2013) Pharmacotherapy of scleritis: current paradigms and future directions. Expert Opinion on Pharmacotherapy 14:4, pages 411-424.
Read now
Read now
Emmett T. Cunningham$suffix/text()$suffix/text(), Debra A. Goldstein & Manfred Zierhut. (2012) Uveitis Treatment Trials—A Cross-study Perspective. Ocular Immunology and Inflammation 20:2, pages 63-67.
Read now
Read now
Articles from other publishers (29)
Sedat Arıkan, Soner Guven, Muserref Hilal Sehitoglu & Sait Elmas. (2023) The possible effect of topically applied azithromycin and moxifloxacin on the alleviation of uveitis. International Ophthalmology.
Crossref
Crossref
Vita Louisa Sophie Dingerkus, Matthias Dieter Becker & Deshka Doycheva. (2022) Therapie der Uveitis mit Biologika. Klinische Monatsblätter für Augenheilkunde 239:05, pages 686-694.
Crossref
Crossref
Anji Xiong, Deng Liu, Huini Chen, Guancui Yang, Chen Xiong, Yu Shuai, Linqian He, Zepeng Guo, Liangwen Zhang, Yuan Yang, Beibei Cui & Shiquan Shuai. (2021) The Efficacy and Safety of Infliximab in Refractory Noninfectious Uveitis: A Meta-Analysis of Observational Studies. Frontiers in Pharmacology 12.
Crossref
Crossref
Srilakshmi M Sharma, Erika Damato, Ann E Hinchcliffe, Colm D Andrews, Katie Myint, Richard Lee & Andrew D Dick. (2021) Long-term efficacy and tolerability of TNFα inhibitors in the treatment of non-infectious ocular inflammation: an 8-year prospective surveillance study. British Journal of Ophthalmology 105:9, pages 1256-1262.
Crossref
Crossref
Mathilde Leclercq, Vincent Langlois, Nicolas Girszyn, Maëlle Le Besnerais, Ygal Benhamou, Hervé Levesque, Marc Muraine & Julie Gueudry. (2020) Comparison of conventional immunosuppressive drugs versus anti-TNF-α agents in non-infectious non-anterior uveitis. Journal of Autoimmunity 113, pages 102481.
Crossref
Crossref
Yunwei Hu, Zhaohao Huang, Shizhao Yang, Xiaoqing Chen, Wenru Su & Dan Liang. (2020) Effectiveness and Safety of Anti-Tumor Necrosis Factor-Alpha Agents Treatment in Behcets’ Disease-Associated Uveitis: A Systematic Review and Meta-Analysis. Frontiers in Pharmacology 11.
Crossref
Crossref
Mary Ho, Li Jia Chen, Helena P. Y. Sin, Lawrence P. L. Iu, Marten Brelen, Assunta C. H. Ho, Timothy Y. Y. Lai & Alvin L. Young. (2019) Experience of using adalimumab in treating sight-threatening paediatric or adolescent Behcet’s disease-related uveitis. Journal of Ophthalmic Inflammation and Infection 9:1.
Crossref
Crossref
James T. Rosenbaum, Bahram Bodaghi, Cristobal Couto, Manfred Zierhut, Nisha Acharya, Carlos Pavesio, Mei-Ling Tay-Kearney, Piergiorgio Neri, Kevin Douglas, Sophia Pathai, Alexandra P. Song, Martina Kron & C. Stephen Foster. (2019) New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review. Seminars in Arthritis and Rheumatism 49:3, pages 438-445.
Crossref
Crossref
Amruta Trivedi & Constance Katelaris. (2019) The use of biologic agents in the management of uveitis. Internal Medicine Journal 49:11, pages 1352-1363.
Crossref
Crossref
Noy Ashkenazy, Ujwala S. Saboo, Ashley Abraham, Cristiana Ronconi & Jennifer H. Cao. (2019) Successful treatment with infliximab after adalimumab failure in pediatric noninfectious uveitis. Journal of American Association for Pediatric Ophthalmology and Strabismus 23:3, pages 151.e1-151.e5.
Crossref
Crossref
Anka Stanojević-Paović, Aleksandra Radosavljević, Gordana Zlatanović, Ana Oros, Sonja Cekić, Aleksandra Ilić & Svetlana Jovanović. (2018) Recommendations for treatment of non-infectious uveitis. Medicinski casopis 52:2, pages 56-63.
Crossref
Crossref
Sean Fine, Judy Nee, Pranjal Thakuria, Brian Duff, Francis A. Farraye & Samir A. Shah. (2017) Ocular, Auricular, and Oral Manifestations of Inflammatory Bowel Disease. Digestive Diseases and Sciences 62:12, pages 3269-3279.
Crossref
Crossref
Alejandro Gómez-Gómez, Estíbaliz Loza, Maria Piedad Rosario, Gerard Espinosa, José M. García Ruiz de Morales, Jose M. Herreras, Santiago Muñoz-Fernández & Miguel Cordero-Coma. (2017) Efficacy and safety of immunomodulatory drugs in patients with anterior uveitis. Medicine 96:42, pages e8045.
Crossref
Crossref
Giuseppe Lopalco, Claudia Fabiani, Jurgen Sota, Orso Maria Lucherini, Gian Marco Tosi, Bruno Frediani, Florenzo Iannone, Mauro Galeazzi, Rossella Franceschini, Donato Rigante & Luca Cantarini. (2017) IL-6 blockade in the management of non-infectious uveitis. Clinical Rheumatology 36:7, pages 1459-1469.
Crossref
Crossref
Sergio Schwartzman. 2017. Uveitis. Uveitis
301
316
.
Glenn J. Jaffe, Andrew D. Dick, Antoine P. Brézin, Quan Dong Nguyen, Jennifer E. Thorne, Philippe Kestelyn, Talin Barisani-Asenbauer, Pablo Franco, Arnd Heiligenhaus, David Scales, David S. Chu, Anne Camez, Nisha V. Kwatra, Alexandra P. Song, Martina Kron, Samir Tari & Eric B. Suhler. (2016) Adalimumab in Patients with Active Noninfectious Uveitis. New England Journal of Medicine 375:10, pages 932-943.
Crossref
Crossref
Sergio Schwartzman. (2016) Advancements in the management of uveitis. Best Practice & Research Clinical Rheumatology 30:2, pages 304-315.
Crossref
Crossref
Bianka Sobolewska, Deshka Doycheva, Christoph Deuter & Manfred Zierhut. 2016. Uveitis: An Update. Uveitis: An Update
33
42
.
Massimo Accorinti & Manfred Zierhut. 2016. Intraocular Inflammation. Intraocular Inflammation
293
307
.
Sergio Schwartzman & Monica Schwartzman. (2014) The Use of Biologic Therapies in Uveitis. Clinical Reviews in Allergy & Immunology 49:3, pages 307-316.
Crossref
Crossref
M. Elaine Husni. (2015) Comorbidities in Psoriatic Arthritis. Rheumatic Disease Clinics of North America 41:4, pages 677-698.
Crossref
Crossref
Erik Letko, Steven Yeh, C. Stephen Foster, Uwe Pleyer, Mitchell Brigell & Cynthia L. Grosskreutz. (2015) Efficacy and Safety of Intravenous Secukinumab in Noninfectious Uveitis Requiring Steroid-Sparing Immunosuppressive Therapy. Ophthalmology 122:5, pages 939-948.
Crossref
Crossref
Alexis Ogdie, Sergio Schwartzman & M. Elaine Husni. (2015) Recognizing and managing comorbidities in psoriatic arthritis. Current Opinion in Rheumatology 27:2, pages 118-126.
Crossref
Crossref
Alexis Ogdie, Sergio Schwartzman, Lihi Eder, Ajesh B. Maharaj, Devy Zisman, Siba P. Raychaudhuri, Soumya M. Reddy & Elaine Husni. (2014) Comprehensive Treatment of Psoriatic Arthritis: Managing Comorbidities and Extraarticular Manifestations. The Journal of Rheumatology 41:11, pages 2315-2322.
Crossref
Crossref
Lorenzo Vannozzi, Ugo Menchini & Massimo Accorinti. 2014. Behçet's Syndrome. Behçet's Syndrome
97
115
.
Elisabetta Miserocchi, Umberto De Benedetto & Giulio Modorati. 2014. Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders. Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders
135
159
.
Dana M. Hornbeak & John H. Kempen. 2014. Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders. Immune Modulation and Anti-Inflammatory Therapy in Ocular Disorders
231
244
.
Lana M. Rifkin, Andrea D. Birnbaum & Debra A. Goldstein. (2013) TNF Inhibition for Ophthalmic Indications: Current Status and Outlook. BioDrugs 27:4, pages 347-357.
Crossref
Crossref
Sanjay R. Kedhar. (2013) Research in Uveitis and Ocular Inflammation, 2011 to 2012. Asia-Pacific Journal of Ophthalmology 2:3, pages 187-198.
Crossref
Crossref